http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2015511587-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-13 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J1-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J1-0007 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J1-00 |
| filingDate | 2012-04-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2015-04-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2015511587-A |
| titleOfInvention | Crystalline compound of androstane-3β, 5α, 6β-triol and process for producing the same |
| abstract | The present invention relates to four types of crystalline compounds of androstane-3β, 5α, 6β-triol (abbreviated as YC-6) (ie, A crystal form YC-6, B crystal form YC-6, C crystal form YC). -6, D crystal form YC-6) and methods for their preparation. These four types of crystalline compounds are characterized by having significant differences between parameters such as lattice constant, 2θ of X-ray powder diffraction and intensity, melting point. Research on the crystal polymorphism of androstane-3β, 5α, 6β-triol has important implications for further studies of its medicinal properties, bioavailability, and stability. [Selection] Figure 1 |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2015517418-A |
| priorityDate | 2012-03-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 35.